Physician

Girish Chiyyarath Vallabhan, M.D.

According to 2025 Medicare claims, Girish Vallabhan, M.D. (NPI: 1982607586) practices urology in the Lubbock, TX market, with the plurality of this provider's patient population coming from Lubbock, TX. This provider's primary affiliated billing organization is LUBBOCK UROLOGY CLINIC, LLP (NPI: 1629012844; TIN: 751514281) and primary practice location at 79424-0803. Vallabhan is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Vallabhan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,304 traditional Medicare patients, billed 16,358 HCPCS/CPT codes, and received $445,306 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 4,867 prescription claims across 1,061 beneficiaries totaling $711,290 in drug costs, led by Xtandi (Enzalutamide). DME data shows 48 claims. Open Payments data shows 41 records totaling $1,775. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $214,344 to $711,290. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $1,188 to $115.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$275K$549K2015 Medicare payment: $437,006 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $394,366 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $428,789 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $346,155 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $542,422 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $492,996 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $473,778 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $435,222 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $549,330 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $445,306 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,3579,654$437,006
20161,47310,503$394,366
20171,2959,522$428,789
20181,31410,350$346,155
20191,41316,372$542,422
20201,32515,190$492,996
20211,34816,253$473,778
20221,20214,805$435,222
20231,46119,491$549,330
20241,30416,358$445,306

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$356K$711K2015 Drug cost: $214,344 (USD; Tot_Drug_Cst)2016 Drug cost: $226,260 (USD; Tot_Drug_Cst)2017 Drug cost: $324,648 (USD; Tot_Drug_Cst)2018 Drug cost: $437,840 (USD; Tot_Drug_Cst)2019 Drug cost: $447,847 (USD; Tot_Drug_Cst)2020 Drug cost: $532,873 (USD; Tot_Drug_Cst)2021 Drug cost: $432,432 (USD; Tot_Drug_Cst)2022 Drug cost: $572,122 (USD; Tot_Drug_Cst)2023 Drug cost: $545,867 (USD; Tot_Drug_Cst)2024 Drug cost: $711,290 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20157172,906$214,344
20167643,391$226,260
20178073,519$324,648
20188974,167$437,840
20198764,164$447,847
20209024,113$532,873
20219564,250$432,432
20229144,242$572,122
20239654,606$545,867
20241,0614,867$711,290

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$9.5K$19K2015 Medicare payment: $11,734 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $7,780 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $18,949 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $13,394 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $15,455 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $16,180 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $11,237 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $13,290 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $13,144 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $10,475 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R127$11,734
2016N/R106$7,780
201716107$18,949
20181278$13,394
201913121$15,455
20201394$16,180
2021N/R63$11,237
2022N/R76$13,290
2023N/R55$13,144
2024N/R48$10,475

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more9521,294$58
84153Psa (prostate specific antigen) measurement, total8301,201$18
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's687818$12
36415Insertion of needle into vein for collection of blood sample8811,330$9
81003Automated urinalysis test1,1411,794$2

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XtandiEnzalutamide19570$269,382
ErleadaApalutamide17510$252,230
MyrbetriqMirabegron763,660$53,746
FinasterideFinasteride1,427121,771$22,440
EstradiolEstradiol30616,913$21,423

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4351Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), eachNN/R32$10,373
A4332Lubricant, individual sterile packet, eachNN/R16$102

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.41$1,775PROCEPT BioRobotics Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Girish Chiyyarath Vallabhan, M.D.?

Tedicare shows public-source Medicare data for Girish Chiyyarath Vallabhan, M.D. (NPI 1982607586), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Girish Chiyyarath Vallabhan, M.D. have ACO affiliation data?

Girish Chiyyarath Vallabhan, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Girish Chiyyarath Vallabhan, M.D.?

Girish Chiyyarath Vallabhan, M.D. is linked to LUBBOCK UROLOGY CLINIC, LLP (billing NPI 1629012844) in the available physician profile data.

Does Girish Chiyyarath Vallabhan, M.D. have Open Payments data?

Girish Chiyyarath Vallabhan, M.D. has 41 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.